Stocklytics Platform
Asset logo for symbol VTRS
Viatris
VTRS61
$12.56arrow_drop_up0.43%$0.05
S&P500
Asset logo for symbol VTRS
VTRS61

$12.56

arrow_drop_up0.43%

Performance History

Chart placeholder
Key Stats
Open$12.50
Prev. Close$12.51
EPS-0.73
Dividend-
Next Earnings DateDec 13, 2024
PE Ratio-
LOWHIGH
Day Range12.50
12.62
52 Week Range8.74
13.62
Ratios
Revenue-
EPS-0.73

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Viatris (VTRS)

Viatris Inc (VTRS) is a pharmaceutical company that specializes in the development, manufacturing, and distribution of generic and biosimilar medicines. The company was formed through a merger between Mylan N.V. and Upjohn Inc., a division of Pfizer Inc., in November 2020. Viatris aims to improve access to high-quality, affordable medicines for patients worldwide.
The stock price history of Viatris Inc (VTRS) reflects the company's performance in the market. Investors can track the fluctuations in the stock price over time to make informed investment decisions. It is important to note that past performance is not indicative of future results.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Scott Andrew Smith
Headquarters
Canonsburg
Employees
38000
Exchange
NASDAQ
add Viatris  to watchlist

Keep an eye on Viatris

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Viatris 's (VTRS) price per share?

The current price per share for Viatris (VTRS) is $12.56. The stock has seen a price change of $0.05 recently, indicating a 0.44% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Viatris (VTRS)?

For Viatris (VTRS), the 52-week high is $13.62, which is 8.4% from the current price. The 52-week low is $8.74, the current price is 43.76% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Viatris (VTRS) a growth stock?

Viatris (VTRS) has shown an average price growth of -2.59% over the past three years. It has received a score of 47 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Viatris as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Viatris (VTRS) stock price performance year to date (YTD)?

As of the latest data, Viatris (VTRS) has a year-to-date price change of 10.32%. Over the past month, the stock has experienced a price change of -4.01%. Over the last three months, the change has been 12.89%. Over the past six months, the figure is 19.55%.
help

Is Viatris (VTRS) a profitable company?

Viatris (VTRS) has a net income of $54.7M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 41.74% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.88% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $6.44B. Operating income is noted at $766.2M. Furthermore, the EBITDA is $2.89B.
help

What is the market capitalization of Viatris (VTRS)?

Viatris (VTRS) has a market capitalization of $14.93B. The average daily trading volume is 12.55, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level